Elizabeth Holmes, the former Theranos CEO convicted of fraud, filed a motion on Tuesday asking a California federal judge for a new trial based on new evidence concerning “star witness” Adam Rosendorff, her former lab director.
According to the motion, Rosendorff left Holmes’ lawyer Lance Wade a 30-second voicemail on August 8 stating that he wanted to visit Holmes and that it would be healing for them both.
An hour and 15 minutes later, Rosendorff showed up at Holmes’ house and her partner answered the door. Rosendorff told her partner said that he had regrets about the trial and it was keeping him up at night. The motion said that Rosendorff believed that “the government made things seem worse than they were,” and “he felt he had done something wrong in connection with Ms. Holmes’ trial.” He felt a conversation with Holmes would help them both.
Holmes’ partner, Billy Evans, later recounted the interaction with Rosendorff in an email to Holmes’ lawyer and described Rosendorff as having a “disheveled” appearance.
“His shirt was untucked, his hair was messy, his voice slightly trembled,” Evans wrote in the email.
Rosendorff’s regrets calls into question his credibility and the way he influenced the jury according to the motion.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
“Dr. Rosendorff’s statements suggest that the government’s presentation of evidence may have misled the jury, whether intentionally or not,” according to the motion. “His statements suggest that there is strong reason to doubt the credibility of a key government witness. And his statements at least raise the possibility of government misconduct.”
Rosendorff was Theranos’ laboratory director from April 2013 to November 2014. He testified for six days during the trial and described instances of inaccurate and irregular lab results, the New York Times reported. He was mentioned in opening and closing arguments “more than any other witness,” according to the motion.
The trial concluded in January when a federal jury convicted Holmes of four counts of fraud, including an investor wire fraud conspiracy count and three substantive wire fraud counts, with wire transfers totaling more than $140 million.
Holmes raised concerns during the trial about Rosendorff’s potential bias in the government’s favor due to pending government investigations into three positions he held after working at Theranos, according to the motion.
The motion cites ethical constraints limiting Holmes’ lawyers from returning Rosendorff’s phone call without consent from Rosendorff’s lawyer. The next day, after Rosendorff visited Holmes’ house, Holmes’ lawyer emailed the lawyer who appeared with Rosendorff at trial. The attorney said there was no need for Holmes’ lawyer to return Rosendorff’s call.
Holmes faces a maximum sentence of twenty years in prison and a fine of $250,000, plus restitution. Her sentencing hearing is scheduled for October 17.
Lawyers for Holmes did not immediately respond to a request for comment.
Photo: TEDMED
